HB 305 — AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO THE DELAWARE DIABETES WELLNESS PILOT PROGRAM WITHIN THE DEPARTMENT OF HEALTH AND SOCIAL SERVICES TO STUDY DIABETIC WELL CARE.
Last action — Passed By Senate. Votes: 21 YES
-
✓Introduced
-
✓In Committee
-
3Passed House
-
4Passed Senate
-
5To Executive
-
6Enacted
This bill has passed the House. Introduced March 05, 2026. It now moves to the second chamber.
Next likely step: consideration and a floor vote in the Senate.
Odds of enactment
High chanceBased on the sponsor, cosponsors, and committee posture, this bill has a high chance of becoming law.
Upgrade to see the exact probability and what's driving it.
A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.
Prognosis
-
Passed House
Current position in the legislative process.
-
28 sponsors
28 primary, 0 co-sponsors signed on.
-
Bipartisan support
Sponsored across 2 parties (15 D · 11 R) — cross-party backing.
-
Cleared a recorded vote
Passed 2 recorded votes so far.
Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.
In plain language
The bill establishes a pilot program to improve diabetes care in Delaware.
This legislation initiates a three-year observational study to enhance diabetes care from reactive to proactive approaches. It aims to improve health outcomes and reduce healthcare costs by incentivizing proper management of diabetes through a partnership with a health system and a technology partner.
What this means for you
- Families: Families of diabetic patients may see improved health outcomes through enhanced care coordination and support.
- Consumers: Consumers with diabetes can benefit from a proactive approach to their healthcare, potentially leading to better health outcomes.
- Healthcare: This means healthcare providers will participate in a structured program aimed at improving diabetes management.
Summary
This Act provides a roadmap via an observational study on a small but representative group of diabetic patients to change standard healthcare from current reactive “sick care” to proactive “well care”. This will be accomplished by using a Delaware health system combined with a technology partner to regularly test, measure and manage, and incentivize diabetic patients and their providers to improve the health outcomes for Delawareans and drive down healthcare costs. The length of the observational study will be 3 years. During that time, data analysis will track results to determine if this Pilot Program shall be renewed and expanded. This Act requires no fiscal note in that this Pilot Program is to be federally funded through the Federal Rural Health Transformation Program.
Bill Text
What changed in the latest version
186 added · 13 removedPlain-language change summary
The amendment adds a requirement for the Secretary to make reasonable efforts to ensure that the patient population enrolled in the Delaware Diabetes Wellness Pilot Program is diverse. This diversity should reflect the racial, ethnic, socioeconomic, geographic, age, and gender characteristics of Delawareans living with Type 2 diabetes, based on available epidemiological data. The change aims to make the study more representative of the communities affected by diabetes in the state.
Hilovsky HOUSE& OFRep. REPRESENTATIVES 153rd GENERAL ASSEMBLY HOUSE AMENDMENT NO.
1Berry TO& HOUSERep. BILL NO.
305Burns AMEND& HouseSen. Bill No.
305Seigfried on& lineSen. 98 by inserting after the phrase “Pilot Program.” the following:
“InPettyjohn recruitingReps. volunteer participants, the Secretary shall make a reasonable effort to work to guarantee that the enrolled patient population reflects the racial, ethnic, socioeconomic, geographic, age, and gender diversity of Delawareans living with Type 2 diabetes, consistent with available epidemiological data on diabetes prevalence across demographic groups in the State.”.
SYNOPSISCollins, ThisDukes, amendmentK. adds specific requirements to make a reasonable effort to work to guarantee the enrolled patient population reflects the racial, ethnic, socioeconomic, geographic, age, and gender diversity of Delawareans living with Type 2 diabetes consistent with available epidemiological data.
Johnson, Michael Smith, Snyder-Hall, Chukwuocha, Jones Giltner, Postles, Cooke, Yearick, Lambert;
Sens.
Buckson, Richardson, Wilson, Hansen, Brown, Cruce, Hocker, Hoffner, Huxtable, Lawson, Lockman, Mantzavinos, Paradee, Pinkney, Poore, Sokola, Sturgeon, Townsend, Walsh HOUSE OF REPRESENTATIVES 153rd GENERAL ASSEMBLY HOUSE BILL NO.
305 AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO THE DELAWARE DIABETES WELLNESS PILOT PROGRAM WITHIN THE DEPARTMENT OF HEALTH AND SOCIAL SERVICES TO STUDY DIABETIC WELL CARE.
WHEREAS, the United States spends $4.3 trillion each year on health care, and last year, nearly 40% of the Delaware budget was spent on healthcare, rising $200 million year over year;
and WHEREAS, direct U.S.
costs per year for diabetes alone is $413 billion making diabetes the costliest disease in our country, and 24% of Delaware’s healthcare expense annually, and 48% - 64% of lifetime medical costs for a diabetic are for complications related to heart disease and stroke;
and WHEREAS, in Delaware, the cost of diabetes care has exceeded $1.1 billion each year for the past 3 years, and this cost is unsustainable;
and WHEREAS, according to research, the lifetime excess medical spending for people with diabetes can be substantial.
For example, if diagnosed at age 40, the additional lifetime medical spending is estimated to be $125,000 - $211,000;
and WHEREAS, reversing Type 2 diabetes could lead to significant savings and a recent study suggests if just 47.7% of cases of Type 2 diabetes nationwide were reversed, the savings in subsequent years could total roughly $137 billion annually, and WHEREAS, nearly 40% of Delawareans are obese, and 34% are classified as overweight, and as obesity increases the risk of chronic diseases and other health problems including:
diabetes, heart disease, stroke, high blood pressure, high cholesterol, kidney, liver, gall bladder disease, sleep apnea, joint problems, and infertility;
and WHEREAS, nearly 28% of all Delawareans have diabetes or prediabetes, and according to the Centers for Disease Control and Prevention (CDC), more than 8 of 10 adults nationally have prediabetes and are not aware of their condition, and those with diabetes often have related co-morbidities, related metabolic syndrome such as:
hypertension, abnormal cholesterol or triglyceride levels, heart disease, and stroke;
and HR :
RDS :
AFJ Page 1 of 6 Released:
03/04/2026 01:53 PM WHEREAS, data supports other maladies like atherosclerosis, neuropathy, retinal changes leading to vision changes or blindness, and Alzheimer’s disease are also associated complications caused by diabetes;
and WHEREAS, of employees and dependents enrolled in the Delaware Group Health Insurance Plan, nearly 80% with diabetes have multiple secondary diseases (co-morbidities) directly related to their diabetes diagnosis;
and WHEREAS, new costly lifelong medicines are now being marketed and prescribed to fight the effects of diabetes in children as well as adults, with costs starting at $800 per month and higher;
the minimum cost for these classes of medicines alone is $9,600 per patient per year, and medications, while costly, may also have significant side effects such as muscle wasting that can cause complications such as fracture risks in the elderly, especially females, brain fog, inflammation of the pancreas, and other complications indicating these medications are not a panacea;
and WHEREAS, the healthcare expenses for prediabetes and diabetes patients averages 2.3 – 3 times higher than for a person without diabetes/prediabetes;
and according to a CDC study last reviewed in 2024, type 2 diabetes diagnosed at the age of 50 shortened life expectancy by an average of 5–6 years;
and WHEREAS, according to a University of Eastern Finland study of 1.5 million patients, diabetes diagnosed at the age of 40, reduced potential life years by about 10 years, and diabetes diagnosed in the 30’s meant an average reduction in life expectancy of approximately 13–14 years and the comparison was based on the overall life expectancy by age group calculated for both the European Union and US populations;
and WHEREAS, the CDC also confirms lifestyle changes can extend the life of a diabetic by 3 years, and in some, up to 10 years;
and WHEREAS, Delaware health care spending continues to grow at an alarming rate, even a modest 5% shift in carefully measured and managed diabetic health metrics in patients has the potential to decrease health care spending on diabetes and metabolic syndrome, significantly, likely millions of dollars per year;
and WHEREAS, dietary changes to support healthy eating habits using whole foods or minimally processed foods, sugar reduction, carbohydrate reduction, increasing fatty fish, increased movement throughout the day with mild to moderate exercise, while maintaining good sleep habits, make it possible to fully reverse or reduce the severity of many Type 2 diabetes patients, and therefore the depth and severity of related diseases;
and WHEREAS, it is now possible with technology to help patients measure and manage food consumption;
and, WHEREAS, diabetes and metabolic syndrome are more prevalent with age, with nearly 24% of Delawareans aged 65 and older having diabetes, followed by ages 55 – 64 with a diabetes percentage of greater than 19%, and all age groups have shown an increase in diabetes;
and HR :
RDS :
AFJ Page 2 of 6 Released:
03/04/2026 01:53 PM WHEREAS, in the Medicare population, the cost of diseases associated with diabetes and heart disease continue to increase at an unsustainable pace:
most recently costing $5,876 per year per resident, and chronic kidney disease likely associated with diabetes additionally costs an estimated $38,000 per year, and WHEREAS, recent attempts to improve the health and wellness of Delaware residents with diabetes and related diseases have largely not been effective and medical care costs continue to rise;
Show all 134 changed lines (94 more)
and WHEREAS, therefore, new innovative solutions to the diabetes and related metabolic health crises must be explored.
NOW, THEREFORE:
BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF DELAWARE:
Section 1.
Amend Title 16 of the Delaware Code by making deletions as shown by strike through and insertions as shown by underline as follows:
Chapter 21A.
Diabetes Wellness Act Pilot Program.
§ 2101A.
Intent.
It is the intent of the General Assembly to improve the health and wellness of the residents of Delaware with diabetes, and related metabolic disease.
Accordingly, there is a need to explore and find ways to improve healthcare relating to diabetes, and to control and lower the long-term medical cost relating to this disease.
§ 2102A.
The Delaware Diabetic Wellness Pilot Program is established.
The Delaware Diabetic Wellness Pilot Program (Pilot Program) is established and shall be administered by the Secretary of the Department of Health and Social Services (DHSS), who must work with the Delaware healthcare system and physicians in partnership with technology/technologies companies, selected by the Secretary, to deliver focused and targeted healthcare protocols to a measurable volunteer group of patients that are diabetic meeting the specified criteria for admittance to this program and their physicians.
§ 2103A.
Purpose.
(a) The purpose of this Pilot Program is to measure the impact of changing healthcare from being reactive “sick care” to being proactive “well care” by studying diabetic healthcare recipients in an observational study employing a measure and manage system.
The Pilot Program will establish baseline health data for each participant through physician- led laboratory testing.
Comparative laboratory studies will be completed at regular intervals to monitor progress and compare values.
Additionally, utilizing a technology that will in real time measure and monitor blood glucose while tracking other diabetes related metrics embedded within the technology will provide the most up to date individually specific health monitoring tailored to each participant, in effect creating personalized medicine.
AFJ Page 13 of 16 Released:
05/14/202603/04/2026 09:3401:53 AMPM 080153027080 (b) The Pilot Program will allow physician led healthcare teams of providers to utilize sophisticated technology to suggest food content measurement and portion control recommendations, suggested dietary modifications, and supplement recommendations.
Dietary counseling by specially trained dieticians and diabetic care coordinators will enable the patients to be closely monitored and counseled for lifestyle changes such as reducing highly processed foods, and offer real time advice and mitigation strategies as provided by a continuous glucose monitoring system “CGM” to include a functional application that provides real time guidance to the patient on patient food and food combination choices and to include technology that alerts patients when blood sugar levels rise or fall below norms established by the healthcare team.
The selected CGM/app system must be compatible to synch with healthcare team medical records for Diabetic Patient Care Coordinators to monitor real time changes.
Additionally, other technologies may be included as deemed valuable by the healthcare team after consultation with DHSS and approved by the secretary..
(c) When seasonally available, fresh whole foods will be marketed by the Delaware Department of Agriculture’s Delaware Grown brand initiative, assisting patients in selecting farmers markets, farm stands, or retail outlets to source specific whole foods locally grown to integrate into their diet.
§ 2104A.
Request for proposals;
process to enlist volunteers for program.
(a) The Secretary shall develop a request for proposals (RFP) from technology providers and others as needed and shall list specifications listed within the requirements for the Pilot Program needed to comply with this program.
Additionally, the Secretary shall coordinate with the Delaware Health Information Network (DHIN) and the local Delaware medical system selected to develop a process to enlist the voluntary participation of at least 400 but no more than 500 participants into this Pilot Program.
DHIN will coordinate with the Delaware medical system to compile statistics on 2 distinct groups of patients with Type 2 Diabetes:
volunteers who participate in the Pillot Program, and a group of no less than 200 deidentified Type 2 diabetic patients exhibiting similar demographic characteristics as those participating in the Pilot Program.
These patients will remain deidentified but tracked and reported for comparison of progress and outcomes to the patients in the Pilot Program by DHIN.
Additionally, the physician-led healthcare team for each accepted volunteer patient also will be enlisted to assist the monitoring and reporting of information needed for the Pilot Program and the development of an individualized healthcare plan for each patient in the Pilot Program.
This will include patient care coordinators and dieticians specifically trained in requirements for this Pilot Program.
(b) All information made available to the Pilot Program must be in compliance with the Health Insurance Portability and Accountability Act (HIPAA).
HR :
RDS :
AFJ Page 4 of 6 Released:
03/04/2026 01:53 PM (c) If the process under subsection (a) of this section fails to produce at least 400 volunteer patients, the Secretary may open this Pilot Program to healthcare plans to provide qualified Delaware volunteer patients and their physicians.
§ 2105A.
Baseline healthcare data.
(a) As this program is designed to change “sick care” to “well care” for diabetic enrollees, and it is critical the RFP list in detail the following:
At the beginning of a patient’s enrollment into this Pilot Program, their physician led healthcare team must establish baseline health data through testing protocols and metrics, and utilizing a technology individually tailored to each patient.
(b) At the Pilot Program outset, every 3 months the baseline data must be compared to the current real-time data to measure the effectiveness of each patient’s individual healthcare management plan.
Laboratory testing will initially be repeated every 6 months.
As the results are compared to previous data points, adjustments in patient medications, diet, exercise, and sleep patterns will be considered.
§ 2106A.
Individual healthcare management plan.
The physician-led healthcare team for each patient participating in this Pilot Program must establish an individualized healthcare management plan for their patients.
Admission to the program will be limited to those patients with a Hemoglobin A1c range including 6.5% to 10.0%.
This plan must, at a minimum, assess the following:
weight:
overweight or obese;
diagnosis of diabetes;
assess blood pressure control;
asses blood lipids;
assess cardiovascular health and measuring:
waist circumference, fasting glucose, blood pressure, fasting insulin level, Hemoglobin Alc, lipid panel to include:
total cholesterol, HDL, LDL, cholesterol to triglyceride/HDL cholesterol ratio level, high sensitivity C reactive protein, vitamin D level, urine albumin to creatinine ratio (UACR), vitamin B levels for patients on Melformin, and magnesium level.
Any RFP must specify these tests.
Additionally, initial and regular consultation with dieticians who have completed topic appropriate Lifestyle Medicine training related to diet and food consumption will be integrated in an individual basis as directed by the physician-led healthcare team.
Also tabulated and tracked, will be the number of primary care, specialty care, and Emergency Department/Urgent care visits, and planned and unplanned hospitalizations.
All members of the healthcare team will be required to participate in lifestyle/functional Continuing Medical Education (CME) to familiarize with the protocol requirements of this Pilot Program.
The leaders of the Delaware healthcare system will specify course topics necessary to fulfill the education requirement.
§ 2107A.
Control Group.
For comparison purposes, the RFP will specify data collection compiled and analyzed by DHIN that will identify a comparable-sized group of patients that are not in the study, whose data would remain deidentified.
§ 2108A.
Delaware Health Information Network (DHIN) Reports.
HR :
RDS :
AFJ Page 5 of 6 Released:
03/04/2026 01:53 PM DHIN will report to the Secretary, the Governor, and the General Assembly the summary results from this study every 6 months after the implementation date until the final report is submitted.
Section 2.
This Act shall be effective immediately and shall be implemented 90 days after the Secretary gives notice published in the Register of Regulations that the Secretary has selected the technology company under § 2102A of Title 16, and at least 400 but not exceeding 500 volunteer patients have been recruited to participate in the Pilot Program.
Section 3.
This Act is to be federally funded through the Federal Rural Health Transformation Program and therefore requires no fiscal note.
Section 4.
The Delaware Diabetic Wellness Pilot Program established by this Act shall sunset 3 years after its implementation date unless otherwise extended by act of the General Assembly.
DHIN will prepare and submit a report detailing the progress of the Pilot Program after the first 6 months from the start of the program, and every 6 months thereafter to closely monitor patient health metrics progress as compared to the control group and cost savings to the state.
If at any time during the study the results are significantly positive, the Secretary can discontinue the study and expand the program to benefit more Delawareans.
The Secretary, with analysis of collected metrics, will determine, with consultation of the Sunset Committee, whether to continue or expand the Pilot Program.
All reports will be sent to the Secretary of DHSS, the Governor, the Secretary of the Senate for distribution to all Senators, the Chief Clerk of the House of Representatives for distribution to all Representatives, the Director and Librarian of the Division of Legislative Services, and the Director of the Delaware Public Archives.
SYNOPSIS This Act provides a roadmap via an observational study on a small but representative group of diabetic patients to change standard healthcare from current reactive “sick care” to proactive “well care”.
This will be accomplished by using a Delaware health system combined with a technology partner to regularly test, measure and manage, and incentivize diabetic patients and their providers to improve the health outcomes for Delawareans and drive down healthcare costs.
The length of the observational study will be 3 years.
During that time, data analysis will track results to determine if this Pilot Program shall be renewed and expanded.
This Act requires no fiscal note in that this Pilot Program is to be federally funded through the Federal Rural Health Transformation Program.
HR :
RDS :
AFJ Page 6 of 6 Released:
03/04/2026 01:53 PM 0801530215
Show all 134 changed rows (94 more)
Action History
-
Passed By Senate. Votes: 21 YES
-
Reported Out of Committee (Health & Social Services) in Senate with 6 On Its Merits
-
Assigned to Health & Social Services Committee in Senate
-
Passed By House. Votes: 39 YES 2 ABSENT
-
Amendment HA 1 to HB 305 - Passed In House by Voice Vote
-
Amendment HA 1 to HB 305 - Introduced and Placed With Bill
-
Reported Out of Committee (Health & Human Development) in House with 9 On Its Merits
-
Introduced and Assigned to Health & Human Development Committee in House
Sponsors
- Stell Parker Selby · Primary
- Ray Seigfried · Primary
- John "Jack" Walsh · Primary
- Bryan Townsend · Primary
- Laura V. Sturgeon · Primary
- David P. Sokola · Primary
- Nicole Poore · Primary
- Marie Pinkney · Primary
- Trey Paradee · Primary
- Spiros Mantzavinos · Primary
- Josue O Ortega · Primary
- Dave G. Lawson · Primary
- Russell Huxtable · Primary
- Darius J. Brown · Primary
- David L. Wilson · Primary
- Lyndon D. Yearick · Primary
- Franklin D. Cooke · Primary
- Charles S Postles Jr. · Primary
- Valerie Jones Giltner · Primary
- Claire Snyder-Hall · Primary
- Michael F. Smith · Primary
- Timothy D. Dukes · Primary
- Richard G. Collins · Primary
- Brian Pettyjohn · Primary
- Bryant L. Richardson · Primary
- Jeff Hilovsky · Primary
- Melanie Ross Levin · Primary
- Sarah McBride · Primary
Sponsorship breakdown
Export CSV (upgrade) →28 sponsors · 0 co-sponsors · 34 not signed on
Sponsors (28)
- Stell Parker Selby
- Ray Seigfried Democratic
- John "Jack" Walsh Democratic
- Bryan Townsend Democratic
- Laura V. Sturgeon Democratic
- David P. Sokola Democratic
- Nicole Poore Democratic
- Marie Pinkney Democratic
- Trey Paradee Democratic
- Spiros Mantzavinos Democratic
- Josue O Ortega Democratic
- Dave G. Lawson Republican
- Russell Huxtable Democratic
- Darius J. Brown Democratic
- David L. Wilson Republican
- Lyndon D. Yearick Republican
- Franklin D. Cooke Democratic
- Charles S Postles Jr. Republican
- Valerie Jones Giltner Republican
- Claire Snyder-Hall Democratic
- Michael F. Smith Republican
- Timothy D. Dukes Republican
- Richard G. Collins Republican
- Brian Pettyjohn Republican
- Bryant L. Richardson Republican
- Jeff Hilovsky Republican
- Melanie Ross Levin Democratic
- Sarah McBride
Co-sponsors (0)
None.
Not signed on (34)
34 members have not signed on to this bill.
Show all 34 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Votes
| Party | Yea | Nay | Present | Not Voting |
|---|---|---|---|---|
| Democratic | 15 | 0 | 0 | 0 |
| Republican | 6 | 0 | 0 | 0 |
| Total | 21 | 0 | 0 | 0 |
| % of votes cast | 100% | 0% | 0% | 0% |
How each member voted (21)
| Member | Party | Vote |
|---|---|---|
| Bryan Townsend | Democratic | Yea |
| Daniel Cruce | Democratic | Yea |
| Darius J. Brown | Democratic | Yea |
| David P. Sokola | Democratic | Yea |
| John "Jack" Walsh | Democratic | Yea |
| Kyra L. Hoffner | Democratic | Yea |
| Laura V. Sturgeon | Democratic | Yea |
| Marie Pinkney | Democratic | Yea |
| Nicole Poore | Democratic | Yea |
| Ray Seigfried | Democratic | Yea |
| Russell Huxtable | Democratic | Yea |
| S. Elizabeth Lockman | Democratic | Yea |
| Spiros Mantzavinos | Democratic | Yea |
| Stephanie L. Hansen | Democratic | Yea |
| Trey Paradee | Democratic | Yea |
| Brian Pettyjohn | Republican | Yea |
| Bryant L. Richardson | Republican | Yea |
| Dave G. Lawson | Republican | Yea |
| David L. Wilson | Republican | Yea |
| Eric Buckson | Republican | Yea |
| Gerald W. Hocker | Republican | Yea |
| Party | Yea | Nay | Present | Not Voting |
|---|---|---|---|---|
| Democratic | 27 | 0 | 0 | 0 |
| Republican | 12 | 0 | 0 | 2 |
| Total | 39 | 0 | 0 | 2 |
| % of votes cast | 95% | 0% | 0% | 5% |
How each member voted (41)
| Member | Party | Vote |
|---|---|---|
| Alonna Berry | Democratic | Yea |
| Claire Snyder-Hall | Democratic | Yea |
| Cyndie Romer | Democratic | Yea |
| DeShanna U Neal | Democratic | Yea |
| Debra Heffernan | Democratic | Yea |
| Edward S. Osienski | Democratic | Yea |
| Eric Morrison | Democratic | Yea |
| Frank Burns | Democratic | Yea |
| Franklin D. Cooke | Democratic | Yea |
| Josue O Ortega | Democratic | Yea |
| Kamela T Smith | Democratic | Yea |
| Kendra Johnson | Democratic | Yea |
| Kerri Evelyn Harris | Democratic | Yea |
| Kimberly Williams | Democratic | Yea |
| Krista Griffith | Democratic | Yea |
| Larry Lambert | Democratic | Yea |
| Madinah Wilson-Anton | Democratic | Yea |
| Mara Gorman | Democratic | Yea |
| Melanie Ross Levin | Democratic | Yea |
| Melissa Minor-Brown | Democratic | Yea |
| Nnamdi O. Chukwuocha | Democratic | Yea |
| Sean M. Lynn | Democratic | Yea |
| Sherae'a Moore | Democratic | Yea |
| Sophie Phillips | Democratic | Yea |
| Stephanie T. Bolden | Democratic | Yea |
| William Bush | Democratic | Yea |
| William J. Carson | Democratic | Yea |
| Bryan W. Shupe | Republican | Yea |
| Charles S Postles Jr. | Republican | Not Voting |
| Daniel B. Short | Republican | Yea |
| Jeff Hilovsky | Republican | Yea |
| Jeffrey N. Spiegelman | Republican | Yea |
| Jesse R. Vanderwende | Republican | Yea |
| Kevin S Hensley | Republican | Not Voting |
| Lyndon D. Yearick | Republican | Yea |
| Michael F. Smith | Republican | Yea |
| Richard G. Collins | Republican | Yea |
| Ronald E. Gray | Republican | Yea |
| Shannon Morris | Republican | Yea |
| Timothy D. Dukes | Republican | Yea |
| Valerie Jones Giltner | Republican | Yea |
Subjects
Frequently asked questions
- What does HB 305 do?
- This Act provides a roadmap via an observational study on a small but representative group of diabetic patients to change standard healthcare from current reactive “sick care” to proactive “well care”. This will be accomplished by using a Delaware health system combined with a technology partner to regularly test, measure and manage, and incentivize diabetic patients and their providers to improve the health outcomes for Delawareans and drive down healthcare costs. The length of the observational study will be 3 years. During that time, data analysis will track results to determine if this Pilot Program shall be renewed and expanded. This Act requires no fiscal note in that this Pilot Program is to be federally funded through the Federal Rural Health Transformation Program.
- Who sponsors HB 305?
- HB 305 is sponsored by Stell Parker Selby, Ray Seigfried (Democratic), John "Jack" Walsh (Democratic), Bryan Townsend (Democratic), Laura V. Sturgeon (Democratic), David P. Sokola (Democratic), Nicole Poore (Democratic), Marie Pinkney (Democratic), Trey Paradee (Democratic), Spiros Mantzavinos (Democratic), Josue O Ortega (Democratic), Dave G. Lawson (Republican), Russell Huxtable (Democratic), Darius J. Brown (Democratic), David L. Wilson (Republican), Lyndon D. Yearick (Republican), Franklin D. Cooke (Democratic), Charles S Postles Jr. (Republican), Valerie Jones Giltner (Republican), Claire Snyder-Hall (Democratic), Michael F. Smith (Republican), Timothy D. Dukes (Republican), Richard G. Collins (Republican), Brian Pettyjohn (Republican), Bryant L. Richardson (Republican), Jeff Hilovsky (Republican), Melanie Ross Levin (Democratic), and Sarah McBride.
- What is the current status of HB 305?
- This bill has passed the House. Introduced March 05, 2026. It now moves to the second chamber.
- Where can I track HB 305?
- Track HB 305 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on HB 305
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of HB 305
Last checked for changes about 1 month ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →